RE: Still not sure of this....6 Oct 2023 22:12
Agree US has to be our primary market, UK to become secondary. However, I suspect JB is planning going global with it eventually..
Taken from Oncology Compass (albeit a few months old): “There is a clear need in everyday clinical practice for a highly accurate blood test that can screen men for prostate cancer and accurately identify those at risk while sparing those who, up until now, would be subject to unnecessary, expensive, and invasive procedures. This is another example of how our product portfolio can contribute to reducing the total cost of care for global health,” said Dr. Jon Burrows, Chief Executive Officer at Oxford Biodynamics.